Your browser doesn't support javascript.
loading
New persistent opioid use following robotic-assisted, laparoscopic and open surgery inguinal hernia repair.
MacQueen, Ian T; Milky, Gediwon; Shih, I-Fan; Zheng, Feibi; Chen, David C.
Afiliación
  • MacQueen IT; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Milky G; Global Access, Value & Economics, Intuitive Surgical, Sunnyvale, CA, USA.
  • Shih IF; Global Access, Value & Economics, Intuitive Surgical, Sunnyvale, CA, USA.
  • Zheng F; Global Access, Value & Economics, Intuitive Surgical, Sunnyvale, CA, USA.
  • Chen DC; DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Surg Endosc ; 2024 Jul 22.
Article en En | MEDLINE | ID: mdl-39039294
ABSTRACT

INTRODUCTION:

Post-operative prescription opioid use is a known risk factor for persistent opioid use. Despite the increased utilization of robotic-assisted surgery (RAS) for inguinal hernia repair (IHR), little is known whether this minimally invasive approach results in less opioid consumption. In this study, we compare long-term opioid use between RAS versus laparoscopic (Lap) versus open surgery for IHR.

METHODS:

A retrospective cohort study of opioid-naïve patients who underwent outpatient primary IHR was conducted using the Merative™ MarketScan® (Previously IBM MarketScan®) Databases between 2016 and 2020. Patients not continuously enrolled 180 days before/after surgery, who had malignancy, pre-existing chronic pain, opioid dependency, or invalid prescription fill information were excluded. Among patients exposed to opioids peri-operatively, we assessed long-term opioid use as any opioid prescription fill within 90 to 180 days post-surgery. Secondary outcomes were controlled substance schedule II/III opioid fill, and high-dose opioid fill defined as > 50 morphine milligram equivalent per day. An Inverse-probability of treatment weighted logistic regression was used to compare outcomes between groups with p-value of < 0.05 considered statistically significant.

RESULTS:

A total of 41,271 patients were identified (2070 (5.0%) RAS, 16,704 (40.5%) Lap, and 22,497 (54.5%) open surgery). RAS was associated with less likelihood of prescription fills for any opioid (OR 0.78, 95% CI 0.60 to 0.98 versus Lap; OR 0.67, 95% CI 0.52 to 0.85 versus open), and schedule II/III opioid (OR 0.74, 95% CI 0.56 to 0.96 versus Lap; OR 0.68, 95% CI 0.51 to 0.88 versus open), but comparable high-dose opioid fill (OR 0.95, 95% CI 0.54 to 1.55 versus Lap; OR 0.96, 95% CI 0.56 to 1.52 versus open). Lap and open surgery had no significant difference.

CONCLUSION:

In this cohort of patients derived from a national commercial claims dataset, patients undergoing RAS had a decreased risk of long-term opioid use compared to laparoscopic and open surgery patients undergoing IHR.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Surg Endosc Asunto de la revista: DIAGNOSTICO POR IMAGEM / GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Surg Endosc Asunto de la revista: DIAGNOSTICO POR IMAGEM / GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos